loading

Roivant Sciences Ltd Azioni (ROIV) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
27.24%
1.999
1.571 2.17 7.57 9.018
Operating Expenses
10.83%
341.15
307.80 287.09 292.54 283.40
Benefits Costs and Expenses
82.03%
292.37
160.62 271.43 210.62 243.53
Costs And Expenses
82.03%
292.37
160.62 271.43 210.62 243.53
Operating Income/Loss
10.75%
-339.15
-306.23 -284.92 -284.96 -274.38
Income/Loss From Continuing Operations Before Tax
82.57%
-290.37
-159.04 -269.26 -203.05 -234.51
Income Tax Expense/Benefit
233.55%
23.33
6.995 4.649 49.32 -25.57
Income/Loss From Continuing Operations After Tax
88.93%
-313.70
-166.04 -273.91 -252.38 -208.94
Income/Loss From Discontinued Operations, Net Of Tax
-
- - - 327.02
Net Income/Loss
88.93%
-313.70
-166.04 -273.91 -252.38 118.08
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
8.97%
-47.81
-52.52 -50.56 -45.90 -51.31
Basic Average Shares
2.34%
696.86
680.95 680.29 -5.9226 722.72
Diluted Average Shares
2.34%
696.86
680.95 680.29 -5.9226 722.72
Basic Earnings Per Share
123.53%
-0.38
-0.17 -0.33 -0.29 0.23
Diluted Earnings Per Share
123.53%
-0.38
-0.17 -0.33 -0.29 0.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.79
price down icon 0.69%
$52.40
price down icon 2.84%
$90.00
price down icon 5.12%
$142.70
price down icon 0.85%
biotechnology ONC
$282.29
price down icon 1.75%
Capitalizzazione:     |  Volume (24 ore):